Has Avandia been linked to atrial fibrillation?
Avandia (rosiglitazone) is a drug that is used to treat type 2 diabetes in patients by making the body more sensitive to insulin, thereby reducing high blood sugar levels. Research has found data that indicates a link between taking Avandia and future heart problems, in 2007 the U.S. Food and Drug Administration issued a safety alert about this possible problem. At this time, there are class law suits against the manufacturer of the drug, GlaxoSmithKline alleging in the United States and Canada alleging the company did not properly test the drug and subsequently failed to warn patients of the cardiovascular risks posed by it. There is a case in Canada of a patient who had been taking Avandia and was then hospitalized for atrial fibrillation in 2007, this despite his family's insistence that the man had no known heart problems prior to the atrial fibrillation.
Recommended for you
- What Atrial Fibrillation Means
- How to Help a Diabetic Follow Medication Recommendations
- How to Avoid 10 Chronic Diabetes Complications
- What can I do to get my mom to take her diabetes pills, which she doesn't think are keeping her blood sugar in check?
- 12 Common Diabetes Myths Debunked
- See all 837 questions about Diabetes